Brief: Oxigene appoints Bill Schwieterman as President and Chief Executive Officer
12/05/2015 21:00
May 12 (Reuters) - OXiGENE Inc OXGN.O : * Appoints bill schwieterman, m.d., as president and chief executive officer * Company's current CEO, dai chaplin, will become chief scientific officer * Says both drs. schwieterman and chaplin will continue to serve on oxigene's board of directors * Source text for Eikon ID:nGNXVDOECa * Further company coverage OXGN.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas